THE IDENTIFICATION OF NEW ANTIBIOTICS, GLCOEPTIDICI. A FIRST STEP TOWARDS SOLVING THE INFECTIOUS COMPLICATIONS OF CLINICAL POLICIES (Q2043397)
Jump to navigation
Jump to search
Project Q2043397 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | THE IDENTIFICATION OF NEW ANTIBIOTICS, GLCOEPTIDICI. A FIRST STEP TOWARDS SOLVING THE INFECTIOUS COMPLICATIONS OF CLINICAL POLICIES |
Project Q2043397 in Italy |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
28 July 2017
0 references
29 August 2018
0 references
29 June 2018
0 references
ACTYGEA SRL
0 references
Q285765 (Deleted Item)
0 references
45°38'22.27"N, 8°59'53.59"E
0 references
IL SETTORE DELLA SCOPERTA DI NUOVI ANTIBIOTICI, HA PERSO NEL MONDO MOLTO DEL SUO APPEAL, A CAUSA DEGLI ENORMI INVESTIMENTI NECESSARI A PORTARE SUL MERCATO NUOVE ENTIT CHIMICHE. NONOSTANTE QUESTO, LACQUISIZIONE DI RESISTENZE INCROCIATE AGLI ANTIBIOTICI NEI MICRORGANISMI PATOGENI, PORTA ALLA NECESSIT DI INDIVIDUARE NUOVI ANTIBIOTICI IN GRADO DI CONTRASTARE LINSORGENZA DI COMPLICAZIONI INFETTIVE. NEI PAESI SVILUPPATI, LE PATOLOGIE INFETTIVE GRAVI CAUSATE DA MICRORGANISMI MULTIRESISTENTI, COLPI (Italian)
0 references
THE AREA OF THE DISCOVERY OF NEW ANTIBIOTICS LOST IN THE VERY WORLD OF ITS APPEAL, DUE TO THE HUGE INVESTMENTS NEEDED TO BRING NEW CHEMICALS TO THE MARKET. DESPITE THIS, LACQUISITION OF THE CROSS-RESISTANCE OF ANTIBIOTICS IN PATHOGENIC MICROORGANISMS, LEADS TO THE NEED TO IDENTIFY NEW ANTIBIOTICS THAT CAN COUNTERACT THE INFECTIOUS COMPLICATIONS OF INFECTIOUS COMPLICATIONS. IN DEVELOPED COUNTRIES, SERIOUS INFECTIOUS DISEASES CAUSED BY MULTI-DRUG RESISTANT MICROORGANISMS (English)
0 references
LE DOMAINE DE LA DÉCOUVERTE DE NOUVEAUX ANTIBIOTIQUES A PERDU UNE GRANDE PARTIE DE SON ATTRAIT DANS LE MONDE, EN RAISON DES ÉNORMES INVESTISSEMENTS NÉCESSAIRES POUR METTRE DE NOUVELLES ENTITÉS CHIMIQUES SUR LE MARCHÉ. MALGRÉ CELA, L’ACQUISITION DE RÉSISTANCES CROISÉES AUX ANTIBIOTIQUES DANS LES MICROORGANISMES PATHOGÈNES CONDUIT À LA NÉCESSITÉ D’IDENTIFIER DE NOUVEAUX ANTIBIOTIQUES CAPABLES DE CONTRER LES COMPLICATIONS INFECTIEUSES. DANS LES PAYS DÉVELOPPÉS, LES MALADIES INFECTIEUSES GRAVES CAUSÉES PAR DES MICRO-ORGANISMES MULTIRÉSISTANTS, (French)
16 December 2021
0 references
HET GEBIED VAN DE ONTDEKKING VAN NIEUWE ANTIBIOTICA HEEFT VEEL VAN ZIJN AANTREKKINGSKRACHT VERLOREN IN DE WERELD, ALS GEVOLG VAN DE ENORME INVESTERINGEN DIE NODIG ZIJN OM NIEUWE CHEMISCHE ENTITEITEN OP DE MARKT TE BRENGEN. DESONDANKS LEIDT DE VERWERVING VAN KRUISRESISTENTIES TEGEN ANTIBIOTICA IN PATHOGENE MICRO-ORGANISMEN TOT DE NOODZAAK OM NIEUWE ANTIBIOTICA TE IDENTIFICEREN DIE INFECTIEUZE COMPLICATIES KUNNEN TEGENGAAN. IN ONTWIKKELDE LANDEN ERNSTIGE INFECTIEZIEKTEN VEROORZAAKT DOOR MULTIRESISTENTE MICRO-ORGANISMEN, (Dutch)
23 December 2021
0 references
Identifiers
E89J17001260007
0 references